{
  "run_id": "wp-c8f866f2b289cb3de96f2fa1",
  "verdict": "conditional_implement",
  "score": 0.65,
  "confidence": 0.73,
  "decision_policy": "whitepaper_v1",
  "gating": {
    "full_paper_review_completed": true,
    "implementation_ready_design_doc_present": true,
    "machine_readable_artifacts_present": true,
    "theory_assumption_risk": "high",
    "empirical_rigor": "medium_low",
    "external_validity": "low",
    "recommended_mode": "shadow_and_paper_trading_only"
  },
  "rationale": "The architecture is useful and implementation-ready as a staged research workflow, but evidence quality and assumption risk are insufficient for immediate full production deployment with live capital.",
  "rejection_reasons": [
    "Reject immediate full-production deployment because the main theory claims depend on assumptions not validated for the target live regime.",
    "Reject direct live strategy promotion because the empirical setup is narrow (single market and year) with limited ablation transparency.",
    "Reject live-capital execution without cost-aware robustness gates and stronger governance controls for KB updates."
  ],
  "follow_up_recommendations": [
    "Implement writer-judge and outer evaluator loops in deterministic shadow mode first.",
    "Add strict promotion gates for walk-forward robustness, turnover, drawdown, and cost-aware performance.",
    "Run ablation matrix (none, inner-only, outer-only, full-loop) to verify causal benefit.",
    "Introduce KB lifecycle controls: provenance hashes, dedupe, decay/retirement, and quality scoring.",
    "Require human approval before any transition from paper trading to live execution."
  ],
  "requires_followup": true,
  "approved_by": null,
  "approved_at": null
}
